credibility lost completely, taking shareholders for dummies. instos come and exit for profit, shareholders die living in hope! sure akk will be in asx100 in 2 years☺️
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%